J. Keller

[Treatment of Raynaud's phenomenon in scleroderma with a new stable prostacyclin derivative].

O. Hornstein, A. Schönberger, J. Keller, 2008, Deutsche medizinische Wochenschrift.

Deposits of immunoglobulins at the dermo‐epidermal junction in chronic light‐exposed skin: what is the value of the lupus band test?

O. Hornstein, M. Gruschwitz, J. Keller, 1988, Clinical and experimental dermatology.

Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease

O. Hornstein, R. Kammerer, J. Keller, 1983, The British journal of dermatology.

Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma

O. Hornstein, J. Keller, A. Kaltenecker, 2004, Archives of Dermatological Research.

[The thermoregulatory effectiveness of calcitonin in progressive scleroderma].

O. Hornstein, J. Keller, M. Gevatter, 1989, H+G Zeitschrift für Hautkrankeheiten.

Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma.

R. Timpl, T. Krieg, H. Mensing, 1986, The Journal of investigative dermatology.